Back to results
US 12,686,859 B2Granted
Method for selection of high M6P recombinant proteins
AssigneeAmicus Therapeutics, Inc.
InventorsHung V. Do, Russell Gotschall
Life of this patent
Estimating the term…
Abstract
Methods for the production, capturing and purification of recombinant human lysosomal proteins are described. Such recombinant human lysosomal proteins can have high content of mannose-6-phosphate residues. Also described are pharmaceutical compositions comprising such recombinant human lysosomal proteins, as well as methods of treatment and uses of such recombinant human lysosomal proteins.
Claims20
A method for producing purified recombinant human acid alpha-glucosidase (rhGAA), wherein the purified rhGAA comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:
- 2, the method comprising:
- i) in a bioreactor, culturing host cells that secrete the rhGAA;
- ii) removing medium from the bioreactor;
- iii) filtering the medium to provide a filtrate;
- iv) loading the filtrate onto a first chromatography column to capture the rhGAA, wherein the first chromatography column is an anion exchange chromatography (AEX) column, wherein the filtrate is not loaded onto a chromatography column prior to the AEX column;
- and
- v) eluting the rhGAA from the AEX column,
- wherein the purified rhGAA comprises at least 3.0% of the total N-glycans of the rhGAA are in the form of a bis-mannose-6-phosphate (bis-M6P) N-glycan and wherein at least 90% of the purified rhGAA binds to cation-independent mannose-6-phosphate receptor (CIMPR).
5 more elements
Dependencies are inferred from the claim text.